Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia - a case-control study

被引:14
|
作者
Law, Lai Wa [1 ]
Sahota, Daljit Singh [1 ]
Chan, Lin Wai [1 ]
Chen, Min [1 ]
Lau, Tze Kin [1 ]
Leung, Tak Yeung [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Fetal Med Unit, Shatin, Hong Kong, Peoples R China
来源
关键词
Placental growth factor; fms-like tyrosine kinase 1; hypertension; pre-eclampsia; prediction; Chinese; FOR-GESTATIONAL-AGE; DEVELOP PREECLAMPSIA; PAPP-A; 1ST-TRIMESTER; PREGNANCY; RISK; PREDICTION; 2ND-TRIMESTER; HYPERTENSION; ULTRASOUND;
D O I
10.3109/14767058.2010.531309
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Methods. aEuro integral This is a matched case--control study using stored serum samples collected from non-smoking Chinese women with singleton pregnancies who underwent first trimester screening for aneuploidy. Each case that developed PE was matched with a control whose maternal age, weight, gestational age and date of blood collection were within aEuroS +/-+/- 2 years, aEuroS +/-+/- 5 kg, aEuroS +/-+/- 1 day, and aEuroS +/-+/- 2 weeks of the index case, respectively. Non-parametric paired test was used to compare the PlGF and sFlt-1 levels. PlGF and sFlt-1 were transformed to their equivalent multiple of the median (MoM) using the matched control as the expected median value. The 95%% confidence interval (CI) of the estimated median PlGF and sFlt-1 MoM in those with PE was determined. Results. aEuro integral The median PlGF level in the 27 study cases with PE was lower than that of the matched controls (42.9 pg/ml versus 59.8 pg/ml; p aEuroS== aEuroS0.001). The median PIGF MoM was 0.71 (95%% CI 0.63--0.92). There was no statistically significant difference in sFlt-1 levels between those with PE and their matched control (p aEuroS== aEuroS0.648). The median sFlt-1 MoM was 1.01 (95%% CI 0.65--1.3). Conclusions. aEuro integral Women who developed PE had lower serum PlGF levels but normal sFlt-1 levels in the first trimester.
引用
收藏
页码:808 / 811
页数:4
相关论文
共 50 条
  • [1] Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia
    Khalil, A.
    Maiz, N.
    Garcia-Mandujano, R.
    Penco, J. M.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (03) : 324 - 331
  • [2] The Use of Soluble FMS-like Tyrosine Kinase 1/Placental Growth Factor Ratio in the Clinical Management of Pre-eclampsia
    Govender, Nalini
    Moodley, Jagidesa
    Naicker, Thajasvarie
    AFRICAN JOURNAL OF REPRODUCTIVE HEALTH, 2018, 22 (04): : 135 - 143
  • [3] Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor
    Rohra, D. K.
    Zeb, A.
    Qureishi, R. N.
    Azam, S. I.
    Khan, N. B.
    Zuberi, H. S.
    Sikandar, R.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2012, 25 (02): : 68 - 73
  • [4] Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia
    Saleh, L.
    van den Meiracker, A. H.
    Geensen, R.
    Kaya, A.
    van Lennep, J. E. Roeters
    Duvekot, J. J.
    Verdonk, K.
    Steegers, E. A. P.
    Russcher, H.
    Danser, A. H. J.
    Visser, W.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (06) : 751 - 757
  • [5] First trimester placental growth factor and soluble Fms-like tyrosine kinase 1 and risk for preeclampsia
    Thadhani, R
    Mutter, WP
    Wolf, M
    Levine, RJ
    Taylor, RN
    Sukhatme, VP
    Ecker, J
    Karumanchi, SA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02): : 770 - 775
  • [6] Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia
    Li, Jingyu
    Cai, Ailu
    Yuan, Qian
    Ding, Hao
    Zhao, Dan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 145 (02) : 176 - 181
  • [7] Value of a Placental-Specific to Total Soluble fms-Like Tyrosine Kinase 1 Ratio in Women with Pre-eclampsia
    Rowson, S.
    Reddy, M.
    Guingand, D. D.
    Wallace, E.
    Palmer, K.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2019, 59 : 72 - 72
  • [8] The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio
    Buhimschi, C. S.
    Baumbusch, M. A.
    Dulay, A. T.
    Lee, S.
    Wehrum, M.
    Zhao, G.
    Bahtiyar, M. O.
    Pettker, C. M.
    Ali, U. A.
    Funai, E. F.
    Buhimschi, I. A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (03) : 321 - 330
  • [9] Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study
    Levine, Richard J.
    Vatten, Lars J.
    Horowitz, Gary L.
    Qian, Cong
    Romundstad, Pal R.
    Yu, Kai F.
    Hollenberg, Anthony N.
    Hellevik, Alf I.
    Asvold, Bjorn O.
    Karumanchi, S. Ananth
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 1355 - 1358
  • [10] First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy
    Schneuer, Francisco J.
    Nassar, Natasha
    Guilbert, Cyrille
    Tasevski, Vitomir
    Ashton, Anthony W.
    Morris, Jonathan M.
    Roberts, Christine L.
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2013, 3 (04) : 215 - 221